MeSH D007172 - erectile dysfunction
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Sildenafil | Sildenafil Teva |  | 2009-11-30 |  |  |
| Mylan | Tadalafil | Tadalafil Mylan |  | 2014-11-21 |  |  |
| Novartis | Methyltestosterone | Metandren |  | 1982-01-01 |  |  |
| Bausch Health Companies | Methyltestosterone | Android |  | 1982-01-01 |  |  |
| Methyltestosterone | Testred |  | 1982-01-01 |  |  | |
| Merck & Co | Methyltestosterone | Oreton |  | 1982-01-01 |  |  |
| Methyltestosterone | Oreton Methyl |  | 1982-01-01 |  |  | |
| Bayer | Vardenafil | Levitra |  | 2003-03-06 |  |  |
| Vardenafil | Vivanza |  | 2003-03-04 |  |  | |
| Pfizer | Methyltestosterone | Methyltestosterone |  | 1982-01-01 |  |  |
| Sildenafil | Patrex |  | 1998-09-15 |  |  | |
| Eli Lilly | Tadalafil | Cialis |  | 2002-11-12 | $397.2 M | Q4/23-Q3/24 |
| Methyltestosterone | Methyltestosterone |  | 1982-01-01 |  |  | |
| Tadalafil | Tadalafil Lilly |  | 2017-03-22 |  |  | |
| Lannett | Methyltestosterone | Methyltestosterone |  | 1982-11-05 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
44%11/25
Phase 2
38%11/29
Phase 3
48%12/25
Approved: 6Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use